SEARCH

SEARCH BY CITATION

References

  • Albin R. L., Young A. B. and Penney J. B. (1989) The functional anatomy of basal ganglia disorders. Trends Neurosci. 12, 366375.
  • Augood S. J., Penney Jr J. B., Friberg I. K., Breakefield X. O., Young A. B., Ozelius L. J. and Standaert D. G. (1998) Expression of the early-onset torsion dystonia gene (DYT1) in human brain. Ann. Neurol. 43, 669673.
  • Augood S. J., Martin D. M., Ozelius L. J., Breakefield X. O., Penney Jr J. B. and Standaert D. G. (1999) Distribution of the mRNAs encoding torsinA and torsinB in the normal adult human brain. Ann. Neurol. 46, 761769.
  • Augood S. J., Keller-McGandy C. E., Siriani A., Hewett J., Ramesh V., Sapp E., DiFiglia M., Breakefield X. O. and Standaert D. G. (2003) Distribution and ultrastructural localization of torsinA immunoreactivity in the human brain. Brain Res. 986, 1221.
  • Avshalumov M. V., Chen B. T., Marshall S. P., Peña D. M. and Rice M. E. (2003) Glutamate-dependent inhibition of dopamine release in striatum is mediated by a new diffusible messenger, H2O2. J. Neurosci. 23, 27442750.
  • Balcioglu A., Kim M. O., Sharma N., Cha J. H., Breakefield X. O. and Standaert D. G. (2007) Dopamine release is impaired in a mouse model of DYT1 dystonia. J. Neurochem. 102, 783788.
  • Bao L., Avshalumov M. V. and Rice M. E. (2005) Partial mitochondrial inhibition causes striatal dopamine release suppression and medium spiny neuron depolarization via H2O2 elevation, not ATP depletion. J. Neurosci. 25, 1002910040.
  • Benoit-Marand M., Borrelli E. and Gonon F. (2001) Inhibition of dopamine release via presynaptic D2 receptors: time course and functional characteristics in vivo. J. Neurosci. 21, 91349141.
  • Berardelli A., Rothwell J. C., Hallett M., Thompson P. D., Manfredi M. and Marsden C. D. (1998) The pathophysiology of primary dystonia. Brain 121, 11951212.
  • Bergquist F., Jonason J., Pileblad E. and Nissbrandt H. (1998) Effects of local administration of L-, N-, and P/Q-type calcium channel blockers on spontaneous dopamine release in the striatum and the substantia nigra: a microdialysis study in rat. J. Neurochem. 70, 15321540.
  • Breakefield X. O., Blood A. J., Li Y., Hallet M., Hanson P. I. and Standaert D. G. (2008) The pathophysiological basis of dystonias. Nat. Rev. Neurosci. 9, 222234.
  • Bressman S. B. (2004) Dystonia genotypes, phenotypes, and classification. Adv. Neurol. 94, 101107.
  • Bruno M. K., Ravina B., Garraux G. et al. (2004) Exercise-induced dystonia as a preceding symptom of familial Parkinson’s disease. Mov. Disord. 19, 228230.
  • Chen B. T. and Rice M. E. (2001) Novel Ca2+ dependence and time course of somatodendritic dopamine release: substantia nigra versus striatum. J. Neurosci. 21, 78417847.
  • Chen B. T., Moran K. A., Avshalumov M. V. and Rice M. E. (2006) Limited regulation of somatodendritic dopamine release by voltage-sensitive Ca2+ channels contrasted with strong regulation of axonal dopamine release. J. Neurochem. 96, 645655.
  • Chiken S., Shashidharan P. and Nambu A. (2008) Cortically evoked long-lasting inhibition of pallidal neurons in a transgenic mouse model of dystonia. J. Neurosci. 28, 1396713977.
  • Cohen L. G. and Hallett M. (1988) Hand cramps: clinical features and electromyographic patterns in a focal dystonia. Neurology 38, 10051012.
  • Cragg S. J. (2003) Variable dopamine release probability and short-term plasticity between functional domains of the primate striatum. J. Neurosci. 23, 43784385.
  • Dajas-Bailador F. and Wonnacott S. (2004) Nicotinic acetylcholine receptors and the regulation of neuronal signalling. Trends Pharmacol. Sci. 25, 31724.
  • Dang M. T., Yokoi F., McNaught K. S., Jengelley T. A., Jackson T., Li J. and Li Y. (2005) Generation and characterization of Dyt1 DeltaGAG knock-in mouse as a model for early-onset dystonia. Exp. Neurol. 196, 452463.
  • Dang M. T., Yokoi F., Pence M. A. and Li Y. (2006) Motor deficits and hyperactivity in Dyt1 knockdown mice. Neurosci. Res. 56, 470474.
  • Dani J. A. and Bertrand D. (2007) Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system. Annu. Rev. Pharmacol. Toxicol. 47, 699729.
  • Fabbrini G., Brotchie J. M., Grandas F., Nomoto M. and Goetz C. G. (2007) Levodopa-induced dyskinesias. Mov. Disord. 22, 13791389.
  • Fahn S. (1983) High dosage anticholinergic therapy in dystonia. Neurology 33, 12551261.
  • Fahn S., Bressman S. B. and Marsden C. D. (1998) Classification of dystonia. Adv. Neurol. 78, 110.
  • Farmer S. F., Sheean G. L., Mayston M. J., Rothwell J. C., Marsden C. D., Conway B. A., Halliday D. M., Rosenberg J. R. and Stephens J. A. (1998) Abnormal motor unit synchronization of antagonist muscles underlies pathological co-contraction in upper limb dystonia. Brain 121, 801814.
  • Goodchild R. E., Kim C. E. and Dauer W. T. (2005) Loss of the dystonia-associated protein torsinA selectively disrupts the neuronal nuclear envelope. Neuron 48, 923932.
  • Grace A. A. (1991) Phasic versus tonic dopamine release and the modulation of dopamine system responsivity: a hypothesis for the etiology of schizophrenia. Neuroscience 41, 124.
  • Grace A. A. and Bunney B. S. (1984) The control of firing pattern in nigral dopamine neurons: burst firing. J. Neurosci. 4, 28772890.
  • Grundmann K., Reischmann B., Vanhoutte G. et al. (2007) Overexpression of human wildtype torsinA and human DeltaGAG torsinA in a transgenic mouse model causes phenotypic abnormalities. Neurobiol. Dis. 27, 190206.
  • Hallett M. (1981) Bromocriptine for levodopa-induced end-of-dose dystonia. Lancet 317, 616.
  • Herz E. (1944) Dystonia. 1. Historical review: analysis of dystonic symptoms and physiologic mechanisms involved. Arch. Neurol. Psychiatry 51, 305318.
  • Hewett J., Johanson P., Sharma N., Standaert D. and Balcioglu A. (2010) Function of dopamine transporter is compromised in DYT1 transgenic animal model in vivo. J. Neurochem. 113, 228253.
  • Hyland B. I., Reynolds J. N., Hay J., Perk C. G. and Miller R. (2002) Firing modes of midbrain dopamine cells in the freely moving rat. Neuroscience 114, 475492.
  • Ichinose H., Suzuki T., Inagaki H., Ohye T. and Nagatsu T. (1999) Molecular genetics of dopa-responsive dystonia. Biol. Chem. 380, 13551364.
  • Jankovic J. (2009) Treatment of hyperkinetic movement disorders. Lancet Neurol. 8, 844856.
  • Katzenschlager R., Costa D., Gacinovic S. and Lees A. J. (2002) [123I]-FP-CIT-SPECT in the early diagnosis of PD presenting as exercise-induced dystonia. Neurology 59, 19741976.
  • Kim D. S., Szczypka M. S. and Palmiter R. D. (2000) Dopamine-deficient mice are hypersensitive to dopamine receptor agonists. J. Neurosci. 20, 44054413.
  • Kramer P. L., Ozelius L., Brin M. F., Fahn S., Kidd K. K., Gusella J. and Breakefield X. O. (1988) Molecular genetics of an autosomal dominant form of torsion dystonia. Adv. Neurol. 50, 5766.
  • Kramer P. L., Heiman G. A., Gasser T. et al. (1994) The DYT1 gene on 9q34 is responsible for most cases of early limb-onset idiopathic torsion dystonia in non-Jews. Am. J. Hum. Genet. 55, 468475.
  • Li X., Patel J. C., Wang J., Avshalumov M. V., Nicholson C., Buxbaum J. D., Elder G. A., Rice M. E. and Yue Z. (2010) Enhanced motor performance and striatal dopamine transmission with LRRK2 overexpression in mice is eliminated by familial Parkinson’s disease mutation G2019S. J. Neurosci. 30, 17881797.
  • Limberger N., Trout S. J., Kruk Z. L. and Starke K. (1991) “Real time” measurement of endogenous dopamine release during short trains of pulses in slices of rat neostriatum and nucleus accumbens: role of autoinhibition. Naunyn Schmiedebergs Arch. Pharmacol. 344, 623629.
  • Liu X., Tailor J., Wang S., Yianni J., Gregory R., Stein J. and Aziz T. (2004) Reversal of hypertonic co-contraction after bilateral pallidal stimulation in generalised dystonia: a clinical and electromyogram case study. Mov. Disord. 19, 336340.
  • Ljungberg T., Apicella P. and Schultz W. (1992) Responses of monkey dopamine neurons during learning of behavioral reactions. J. Neurophysiol. 67, 145163.
  • Marsden C. D. and Rothwell J. C. (1987) The physiology of idiopathic dystonia. Can. J. Neurol. Sci. 14, 521527.
  • Martella G., Tassone A., Sciamanna G. et al. (2009) Impairment of bidirectional synaptic plasticity in the striatum of a mouse model of DYT1 dystonia: role of endogenous acetylcholine. Brain 132, 23362349.
  • Mink J. W. (2003) The basal ganglia and involuntary movements: impaired inhibition of competing motor patterns. Arch. Neurol. 60, 13651368.
  • Misbahuddin A., Placzek M. R., Taanman J. W., Gschmeissner S., Schiavo G., Cooper J. M. and Warner T. T. (2005) Mutant torsinA, which causes early-onset primary torsion dystonia, is redistributed to membranous structures enriched in vesicular monoamine transporter in cultured human SH-SY5Y cells. Mov. Disord. 20, 432440.
  • Morris G., Arkadir D., Nevet A., Vaadia E. and Bergman H. (2004) Coincident but distinct messages of midbrain dopamine and striatal tonically active neurons. Neuron 43, 133143.
  • Naumann M., Pirker W., Reiners K., Lange K. W., Becker G. and Brücke T. (1998) Imaging the pre- and postsynaptic side of striatal dopaminergic synapses in idiopathic cervical dystonia: a SPECT study using [123I] epidepride and [123I] beta-CIT. Mov. Disord. 13, 319323.
  • Nausieda P. A., Weiner W. J. and Klawans H. L. (1980) Dystonic foot response of Parkinsonism. Arch. Neurol. 37, 1326.
  • Obeso J. A., Rothwell J. C., Lang A. E. and Marsden C. D. (1983) Myoclonic dystonia. Neurology 33, 825830.
  • Ozelius L. J., Kramer P. L., Moskowitz C. B., Kwiatkowski D. J., Brin M. F., Bressman S. B., Schuback D. E., Falk C. T., Risch N. and De Leon D. (1989) Human gene for torsion dystonia located on chromosome 9q32-q34. Neuron 2, 14271434.
  • Ozelius L. J., Hewett J., Kramer P. et al. (1997) Fine localization of the torsion dystonia gene (DYT1) on human chromosome 9q34: YAC map and linkage disequilibrium. Genome Res. 7, 483494.
  • Page M. E., Bao L., Andre P., Pelta-Heller J., Sluzas E., Gonzalez-Alegre P., Iacovitti L., Rice M. E. and Ehrlich M. E. (2010) Cell-autonomous alteration of dopaminergic transmission by wild type and mutant (ΔE) TorsinA in transgenic mice. Neurobiol. Dis. [Epub ahead of print doi:10.1016/j.nbd.2010.04.016].
  • Palij P., Bull D. R., Sheehan M. J., Millar J., Stamford J., Kruk Z. L. and Humphrey P. P. A. (1990) Presynaptic regulation of dopamine release in corpus striatum monitored in vitro in real time by fast cyclic voltammetry. Brain Res. 509, 172174.
  • Patel J. and Rice M. E. (2006) Dopamine release in brain slices, in Encyclopedia of Sensors (GrimesC. A., DickeyE. C. and PishkoM. V., eds), Vol. 6, pp. 313334. American Scientific Publishers, Stevenson Ranch, CA.
  • Patel J., Trout S. J. and Kruk Z. L. (1992) Regional differences in evoked dopamine efflux in brain slices of rat anterior and posterior caudate putamen. Naunyn Schmiedebergs Arch. Pharmacol. 346, 267276.
  • Patel J., Trout S. J., Palij P., Whelpton R. and Kruk Z. L. (1995) Biphasic inhibition of stimulated endogenous dopamine release by 7-OH-DPAT in slices of rat nucleus accumbens. Br. J. Pharmacol. 115, 421426.
  • Patel J., Mooslehner K. A., Chan P. M., Emson P. C. and Stamford J. A. (2003) Presynaptic control of striatal dopamine neurotransmission in adult vesicular monoamine transporter 2 (VMAT2) mutant mice. J. Neurochem. 85, 898910.
  • Patel J. C., Witkovsky P., Avshalumov M. V. and Rice M. E. (2009) Mobilization of calcium from intracellular stores facilitates somatodendritic dopamine release. J. Neurosci. 29, 65686579.
  • Perlmutter J. S., Tempel L. W., Black K. J., Parkinson D. and Todd R. D. (1997a) MPTP induces dystonia and parkinsonism. Clues to the pathophysiology of dystonia. Neurology 49, 14321438.
  • Perlmutter J. S., Stambuk M. K., Markham J., Black K. J., McGee-Minnich L., Jankovic J. and Moerlein S. M. (1997b) Decreased [18F]spiperone binding in putamen in idiopathic focal dystonia. J. Neurosci. 17, 843850.
  • Petzinger G. M., Walsh J. P., Akopian G. et al. (2007) Effects of treadmill exercise on dopaminergic transmission in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned mouse model of basal ganglia injury. J. Neurosci. 27, 52915300.
  • Phillips P. E. M. and Stamford J. A. (2000) Differential recruitment of N-, P- and Q-type voltage-operated calcium channels in striatal dopamine release evoked by ‘regular’ and ‘burst’ firing. Brain Res. 884, 139146.
  • Phillips P. E. M., Hancock P. J. and Stamford J. A. (2002) Time window of autoreceptor-mediated inhibition of limbic and striatal dopamine release. Synapse 44, 1522.
  • Pisani A., Martella G., Tscherter A., Bonsi P., Sharma N., Bernardi G. and Standaert D. G. (2006) Altered responses to dopaminergic D2 receptor activation and N-type calcium currents in striatal cholinergic interneurons in a mouse model of DYT1 dystonia. Neurobiol. Dis. 24, 318325.
  • Playford E. D., Fletcher N. A., Sawle G. V., Marsden C. D. and Brooks D. J. (1993) Striatal [18F]dopa uptake in familial idiopathic dystonia. Brain 116, 11911199.
  • Rice M. E. and Cragg S. J. (2004) Nicotine amplifies reward-related dopamine signals in striatum. Nat. Neurosci. 7, 583584.
  • Risch N. J., Bressman S. B., DeLeon D., Brin M. F., Burke R. E., Greene P. E., Shale H., Claus E. B., Cupples L. A. and Fahn S. (1990) Segregation analysis of idiopathic torsion dystonia in Ashkenazi Jews suggests autosomal dominant inheritance. Am. J. Hum. Genet. 46, 533538.
  • Romo R. and Schultz W. (1990) Dopamine neurons of the monkey midbrain: contingencies of responses to active touch during self-initiated arm movements. J. Neurophysiol. 63, 592606.
  • Sato K., Sumi-Ichinose C., Kaji R. et al. (2008) Differential involvement of striosome and matrix dopamine systems in a transgenic model of dopa-responsive dystonia. Proc. Natl Acad. Sci. USA 105, 1255112556.
  • Schultz W. (2002) Getting formal with dopamine and reward. Neuron 36, 241263.
  • Sesack S. R., Aoki C. and Pickel V. M. (1994) Ultrastructural localization of D2 receptor-like immunoreactivity in midbrain dopamine neurons and their striatal targets. J. Neurosci. 14, 88106.
  • Sharma N., Baxter M. G., Petravicz J., Bragg D. C., Schienda A., Standaert D. G. and Breakefield X. O. (2005) Impaired motor learning in mice expressing torsinA with the DYT1 dystonia mutation. J. Neurosci. 25, 53515355.
  • Shashidharan P., Sandu D., Potla U., Armata I. A., Walker R. H., McNaught K. S., Weisz D., Sreenath T., Brin M. F. and Olanow C. W. (2005) Transgenic mouse model of early-onset DYT1 dystonia. Hum. Mol. Genet. 14, 125133.
  • Starr P. A., Rau G. M., Davis V., Marks Jr W. J., Ostrem J. L., Simmons D., Lindsey N. and Turner R. S. (2005) Spontaneous pallidal neuronal activity in human dystonia: comparison with Parkinson’s disease and normal macaque. J. Neurophysiol. 93, 31653176.
  • Threlfell S., Clements M. A., Khodai T., Pienaar I. S., Exley R., Wess J. and Cragg S. J. (2010) Striatal muscarinic receptors promote activity dependence of dopamine transmission via distinct receptor subtypes on cholinergic interneurons in ventral versus dorsal striatum. J. Neurosci. 30, 33983408.
  • Torres G. E., Sweeney A. L., Beaulieu J. M., Shashidharan P. and Caron M. G. (2004) Effect of torsinA on membrane proteins reveals a loss of function and a dominant-negative phenotype of the dystonia-associated ΔE-torsinA mutant. Proc. Natl Acad. Sci. USA 101, 1565015655.
  • Trout S. J. and Kruk Z. L. (1992) Differences in evoked dopamine efflux in rat caudate putamen, nucleus accumbens and tuberculum olfactorium in the absence of uptake inhibition: influence of autoreceptors. Br. J. Pharmacol. 106, 452458.
  • Vitek J. L., Chockkan V., Zhang J. Y., Kaneoke Y., Evatt M., DeLong M. R., Triche S., Mewes K., Hashimoto T. and Bakay R. A. (1999) Neuronal activity in the basal ganglia in patients with generalized dystonia and hemiballismus. Ann. Neurol. 46, 2235.
  • Vonsattel J. P. and DiFiglia M. (1998) Huntington disease. J. Neuropathol. Exp. Neurol. 57, 369384.
  • Vonsattel J. P., Myers R. H., Stevens T. J., Ferrante R. J., Bird E. D. and Richardson Jr E. P. (1985) Neuropathological classification of Huntington’s disease. J. Neuropathol. Exp. Neurol. 44, 559577.
  • Walker R. H., Brin M. F., Sandu D., Gujjari P., Hof P. R., Olanow C. and Shashidharan P. (2001) Distribution and immunohistochemical characterization of TorsinA immunoreactivity in rat brain. Brain Res. 900, 348354.
  • Wichmann T. (2008) Commentary: dopaminergic dysfunction in DYT1 dystonia. Exp. Neurol. 212, 242246.
  • Yanagisawa N. and Goto A. (1971) Dystonia musculorum deformans. Analysis with electromyography. J. Neurol. Sci. 13, 3965.
  • Zhang H. and Sulzer D. (2004) Frequency-dependent modulation of dopamine release by nicotine. Nat. Neurosci. 7, 581582.
  • Zhao Y., DeCuypere M. and LeDoux M. S. (2008) Abnormal motor function and dopamine neurotransmission in DYT1 ΔGAG transgenic mice. Exp. Neurol. 210, 719730.
  • Zhou F. M., Liang Y. and Dani J. A. (2001) Endogenous nicotinic cholinergic activity regulates dopamine release in the striatum. Nat. Neurosci. 4, 12241229.
  • Zhuang P., Li Y. and Hallett M. (2004) Neuronal activity in the basal ganglia and thalamus in patients with dystonia. Clin. Neurophysiol. 115, 25422557.